| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |